365 related articles for article (PubMed ID: 21701228)
1. Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.
Ma F; Wang J; Miao R; Zhao W; Wang Q
Neuropsychobiology; 2011; 64(2):102-9. PubMed ID: 21701228
[TBL] [Abstract][Full Text] [Related]
2. The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.
Bretsky P; Guralnik JM; Launer L; Albert M; Seeman TE;
Neurology; 2003 Apr; 60(7):1077-81. PubMed ID: 12682309
[TBL] [Abstract][Full Text] [Related]
3. The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons.
Boyle PA; Buchman AS; Wilson RS; Kelly JF; Bennett DA
Neuroepidemiology; 2010; 34(1):43-9. PubMed ID: 19907191
[TBL] [Abstract][Full Text] [Related]
4. APOE-epsilon4, depressive symptoms, and cognitive decline in Chinese older adults: Singapore Longitudinal Aging Studies.
Niti M; Yap KB; Kua EH; Ng TP
J Gerontol A Biol Sci Med Sci; 2009 Feb; 64(2):306-11. PubMed ID: 19181718
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
Batterham PJ; Bunce D; Cherbuin N; Christensen H
Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
[TBL] [Abstract][Full Text] [Related]
7. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults.
Beydoun MA; Beydoun HA; Kaufman JS; An Y; Resnick SM; O'Brien R; Ferrucci L; Zonderman AB
J Am Geriatr Soc; 2013 Apr; 61(4):525-34. PubMed ID: 23581910
[TBL] [Abstract][Full Text] [Related]
9. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
Klages JD; Fisk JD; Rockwood K
Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C; Winblad B; Fratiglioni L
Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
[TBL] [Abstract][Full Text] [Related]
11. Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner.
Dratva MA; Banks SJ; Panizzon MS; Galasko D; Sundermann EE;
Biol Sex Differ; 2024 Jun; 15(1):45. PubMed ID: 38835072
[TBL] [Abstract][Full Text] [Related]
12. The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.
O'Hara R; Yesavage JA; Kraemer HC; Mauricio M; Friedman LF; Murphy GM
J Am Geriatr Soc; 1998 Dec; 46(12):1493-8. PubMed ID: 9848808
[TBL] [Abstract][Full Text] [Related]
13. APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba.
Hendrie HC; Murrell J; Baiyewu O; Lane KA; Purnell C; Ogunniyi A; Unverzagt FW; Hall K; Callahan CM; Saykin AJ; Gureje O; Hake A; Foroud T; Gao S
Int Psychogeriatr; 2014 Jun; 26(6):977-85. PubMed ID: 24565289
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
Hsiung GY; Sadovnick AD; Feldman H
CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
Chen Q; Wang T; Kang D; Chen L
Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
[TBL] [Abstract][Full Text] [Related]
16. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.
Lim AS; Yu L; Kowgier M; Schneider JA; Buchman AS; Bennett DA
JAMA Neurol; 2013 Dec; 70(12):1544-51. PubMed ID: 24145819
[TBL] [Abstract][Full Text] [Related]
17. Gene-behavior interaction of depressive symptoms and the apolipoprotein E {varepsilon}4 allele on cognitive decline.
Rajan KB; Wilson RS; Skarupski KA; Mendes de Leon CF; Evans DA
Psychosom Med; 2014 Feb; 76(2):101-8. PubMed ID: 24434953
[TBL] [Abstract][Full Text] [Related]
18. APOE genotype and cognitive decline in a middle-aged cohort.
Blair CK; Folsom AR; Knopman DS; Bray MS; Mosley TH; Boerwinkle E;
Neurology; 2005 Jan; 64(2):268-76. PubMed ID: 15668424
[TBL] [Abstract][Full Text] [Related]
19. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.
Dik MG; Jonker C; Bouter LM; Geerlings MI; van Kamp GJ; Deeg DJ
Neurology; 2000 Apr; 54(7):1492-7. PubMed ID: 10751265
[TBL] [Abstract][Full Text] [Related]
20. APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921.
Schiepers OJ; Harris SE; Gow AJ; Pattie A; Brett CE; Starr JM; Deary IJ
Mol Psychiatry; 2012 Mar; 17(3):315-24. PubMed ID: 21263443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
